Drug Safety Alerts issued by Indian Pharmacopoeia Commission, National Coordination Centre-Pharmacovigilance Programme of India (PvPI) from January - June 2021

  • Gufran Ali Pharmacovigilance Associate, PvPI-IPC, Ministry of Health & Family Welfare Government of India, ADR Monitoring Centre, Department of Pharmacology J.N. Medical College & Hospital, AMU, Aligarh


The preliminary analysis of Adverse Drug Reactions (ADRs) from the PvPI database reveals that the following suspected drugs are associated with the ADRs reported by PvPI during January to June 2021